Canlyniadau Chwilio - Randall E. Millikan

  • Dangos 1 - 19 canlyniadau o 19
Mireinio'r Canlyniadau
  1. 1
    Plasmacytoid Urothelial Carcinoma, a Chemosensitive Cancer with Poor Prognosis, and Peritoneal Carcinomatosis

    Plasmacytoid Urothelial Carcinoma, a Chemosensitive Cancer with Poor Prognosis, and Peritoneal Carcinomatosis gan Farshid Dayyani, Bogdan Czerniak, Kanishka Sircar, Mark F. Munsell, Randall E. Millikan, Colin P. Dinney, Arlene O. Siefker‐Radtke

    Cyhoeddwyd 2012
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Phase III Trial of Androgen Ablation With or Without Three Cycles of Systemic Chemotherapy for Advanced Prostate Cancer

    Phase III Trial of Androgen Ablation With or Without Three Cycles of Systemic Chemotherapy for Advanced Prostate Cancer gan Randall E. Millikan, Sijin Wen, Lance C. Pagliaro, Melissa A. Brown, Brenda Moomey, Kim‐Anh Do, Christopher J. Logothetis

    Cyhoeddwyd 2008
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer

    A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced... gan Arlene O. Siefker‐Radtke, Colin P. Dinney, Yu Shen, Dallas Williams, Ashish M. Kamat, H. Barton Grossman, Randall E. Millikan

    Cyhoeddwyd 2012
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Role of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand in Interferon-Induced Apoptosis in Human Bladder Cancer Cells

    Role of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand in Interferon-Induced Apoptosis in Human Bladder Cancer Cells gan Angela Papageorgiou, Laura M. Lashinger, Randall E. Millikan, H. Barton Grossman, William Benedict, Colin P. Dinney, David J. McConkey

    Cyhoeddwyd 2004
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Mammalian target of rapamycin (<scp>mTOR</scp>) inhibitor‐associated non‐infectious pneumonitis in patients with renal cell cancer: predictors, management, and outcomes

    Mammalian target of rapamycin (<scp>mTOR</scp>) inhibitor‐associated non‐infectious pneumonitis in patients with renal cell cancer: predictors, management, and outcomes gan Bradley J. Atkinson, Diana H. Cauley, Chaan S. Ng, Randall E. Millikan, Lianchun Xiao, Paul G. Corn, Eric Jonasch, Nizar M. Tannir

    Cyhoeddwyd 2013
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Prostate cancer progression in the presence of undetectable or low serum prostate‐specific antigen level

    Prostate cancer progression in the presence of undetectable or low serum prostate‐specific antigen level gan Dan Leibovici, Philippe E. Spiess, Piyush K. Agarwal, Shi‐Ming Tu, Curtis A. Pettaway, Kate Hitzhusen, Randall E. Millikan, Louis L. Pisters

    Cyhoeddwyd 2006
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Phase II Clinical Trial of Neoadjuvant Alternating Doublet Chemotherapy With Ifosfamide/Doxorubicin and Etoposide/Cisplatin in Small-Cell Urothelial Cancer

    Phase II Clinical Trial of Neoadjuvant Alternating Doublet Chemotherapy With Ifosfamide/Doxorubicin and Etoposide/Cisplatin in Small-Cell Urothelial Cancer gan Arlene O. Siefker‐Radtke, Ashish M. Kamat, H. Barton Grossman, Dallas Williams, Wei Qiao, Peter F. Thall, Colin P. Dinney, Randall E. Millikan

    Cyhoeddwyd 2009
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Neoadjuvant Chemotherapy in Small Cell Urothelial Cancer Improves Pathologic Downstaging and Long-term Outcomes: Results from a Retrospective Study at the MD Anderson Cancer Center

    Neoadjuvant Chemotherapy in Small Cell Urothelial Cancer Improves Pathologic Downstaging and Long-term Outcomes: Results from a Retrospective Study at the MD Anderson Cancer Center gan Siobhan P. Lynch, Yu Shen, Ashish M. Kamat, H. Barton Grossman, Jay B. Shah, Randall E. Millikan, Colin P. Dinney, Arlene O. Siefker‐Radtke

    Cyhoeddwyd 2012
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    The proteasome inhibitor bortezomib synergizes with gemcitabine to block the growth of human 253JB-V bladder tumors <i>in vivo</i>

    The proteasome inhibitor bortezomib synergizes with gemcitabine to block the growth of human 253JB-V bladder tumors <i>in vivo</i> gan Ashish M. Kamat, Takashi Karashima, Darren W. Davis, Laura M. Lashinger, Menashe Bar‐Eli, Randall E. Millikan, Yu Shen, Colin P. Dinney, David J. McConkey

    Cyhoeddwyd 2004
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Survival outcomes for men with mediastinal germ-cell tumors: The University of Texas M. D. Anderson Cancer Center experience

    Survival outcomes for men with mediastinal germ-cell tumors: The University of Texas M. D. Anderson Cancer Center experience gan Alan Rodney, Nizar M. Tannir, Arlene O. Siefker‐Radtke, Ping Liu, Garrett L. Walsh, Randall E. Millikan, Stephen G. Swisher, Shi‐Ming Tu, Lance C. Pagliaro

    Cyhoeddwyd 2010
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    A Prognostic Gene Expression Signature in the Molecular Classification of Chemotherapy-naïve Urothelial Cancer is Predictive of Clinical Outcomes from Neoadjuvant Chemotherapy: A Phase 2 Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin with Bevacizumab in Urothelial Cancer

    A Prognostic Gene Expression Signature in the Molecular Classification of Chemotherapy-naïve Urothelial Cancer is Predictive of Clinical Outcomes from Neoadjuvant Chemotherapy: A P... gan David J. McConkey, Woonyoung Choi, Yu Shen, I.-Ling Lee, Sima P. Porten, Surena F. Matin, Ashish M. Kamat, Paul G. Corn, Randall E. Millikan, Colin P. Dinney, Bogdan Czerniak, Arlene O. Siefker‐Radtke

    Cyhoeddwyd 2015
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Phase II Presurgical Feasibility Study of Bevacizumab in Untreated Patients With Metastatic Renal Cell Carcinoma

    Phase II Presurgical Feasibility Study of Bevacizumab in Untreated Patients With Metastatic Renal Cell Carcinoma gan Eric Jonasch, Christopher G. Wood, Surena F. Matin, Shi‐Ming Tu, Lance C. Pagliaro, Paul G. Corn, Ana M. Aparicio, Pheroze Tamboli, Randall E. Millikan, Xuemei Wang, John C. Araujo, Wadih Arap, Nizar M. Tannir

    Cyhoeddwyd 2009
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    A Phase l Study of a Tumor-targeted Systemic Nanodelivery System, SGT-94, in Genitourinary Cancers

    A Phase l Study of a Tumor-targeted Systemic Nanodelivery System, SGT-94, in Genitourinary Cancers gan Arlene O. Siefker‐Radtke, Xin-qiao Zhang, Charles C. Guo, Yu Shen, Kathleen F. Pirollo, Sharjeel Sabir, Chris Leung, Cindy A. Leong-Wu, Chi-Ming Ling, Esther H. Chang, Randall E. Millikan, William F. Benedict

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Focus on bladder cancer

    Focus on bladder cancer gan Colin P. Dinney, David J. McConkey, Randall E. Millikan, Xifeng Wu, Menashe Bar‐Eli, Liana Adam, Ashish M. Kamat, Arlene O. Siefker‐Radtke, Tomasz Tuziak, Anita L. Sabichi, H. Barton Grossman, William F. Benedict, Bogdan Czerniak

    Cyhoeddwyd 2004
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Refining Patient Selection for Neoadjuvant Chemotherapy before Radical Cystectomy

    Refining Patient Selection for Neoadjuvant Chemotherapy before Radical Cystectomy gan Stephen H. Culp, Rian J. Dickstein, H. Barton Grossman, Shanna Pretzsch, Sima P. Porten, Siamak Daneshmand, Jie Cai, Susan Groshen, Arlene O. Siefker‐Radtke, Randall E. Millikan, Bogdan Czerniak, Neema Navai, Matthew Wszolek, Ashish M. Kamat, Colin P. Dinney

    Cyhoeddwyd 2013
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Phase I Trial of the Proteasome Inhibitor Bortezomib in Patients With Advanced Solid Tumors With Observations in Androgen-Independent Prostate Cancer

    Phase I Trial of the Proteasome Inhibitor Bortezomib in Patients With Advanced Solid Tumors With Observations in Androgen-Independent Prostate Cancer gan Christos N. Papandreou, Danai Daliani, Darrell Nix, Hong Yang, Timothy Madden, Xuemei Wang, Christine Pien, Randall E. Millikan, Shi‐Ming Tu, Lance C. Pagliaro, Jeri Kim, Julian Adams, Peter J. Elliott, Dixie Esseltine, Alexandria Petrusich, P. Dieringer, Cherie Perez, Christopher J. Logothetis

    Cyhoeddwyd 2004
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    Platinum-Based Chemotherapy for Variant Castrate-Resistant Prostate Cancer

    Platinum-Based Chemotherapy for Variant Castrate-Resistant Prostate Cancer gan Ana M. Aparicio, Andrea Harzstark, Paul G. Corn, Sijin Wen, John C. Araujo, Shi‐Ming Tu, Lance C. Pagliaro, Jeri Kim, Randall E. Millikan, Charles J. Ryan, Nizar M. Tannir, Amado J. Zurita, Paul Mathew, Wadih Arap, Patricia Troncoso, Peter F. Thall, Christopher J. Logothetis

    Cyhoeddwyd 2013
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    The Effectiveness of Off-Protocol Adjuvant Chemotherapy for Patients with Urothelial Carcinoma of the Urinary Bladder

    The Effectiveness of Off-Protocol Adjuvant Chemotherapy for Patients with Urothelial Carcinoma of the Urinary Bladder gan Robert S. Svatek, Shahrokh F. Shariat, Robert E. Lasky, Eila C. Skinner, Giacomo Novara, Seth P. Lerner, Yves Fradet, Patrick J. Bastian, Wassim Kassouf, Pierre I. Karakiewicz, Hans‐Martin Fritsche, Stefan C. Müller, Jonathan I. Izawa, Vincenzo Ficarra, Arthur I. Sagalowsky, Mark Schoenberg, Arlene O. Siefker‐Radtke, Randall E. Millikan, Colin P. Dinney

    Cyhoeddwyd 2010
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    Targeting the interleukin‐11 receptor α in metastatic prostate cancer: A first‐in‐man study

    Targeting the interleukin‐11 receptor α in metastatic prostate cancer: A first‐in‐man study gan Renata Pasqualini, Randall E. Millikan, Dawn R. Christianson, Marina Cardó‐Vila, Wouter H. P. Driessen, Ricardo J. Giordano, Amin Hajitou, Anh Hoang, Sijin Wen, Kirstin F. Barnhart, Wallace B. Baze, Valerie D. Marcott, David H. Hawke, Kim‐Anh Do, Nora M. Navone, Eleni Efstathiou, Patricia Troncoso, Roy R. Lobb, Christopher J. Logothetis, Wadih Arap

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: